Therapy of ovulatory sterility and corpus luteum insufficiency with human menopausal and chorionic gonadotropins.
D000568:Amenorrhea / Q000209:etiology; D002584:Cervix Uteri / Q000187:drug effects; D006063:Chorionic Gonadotropin / Q000627:therapeutic use*; D003338:Corpus Luteum / Q000187:drug effects; D005260:Female; D006062:Gonadotropins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D008593:Menopause; D008598:Menstruation; D010049:Ovarian Diseases / Q000150:complications / Q000188:drug therapy; D010060:Ovulation / Q000187:drug effects; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy; D011247:Pregnancy; D011272:Pregnancy, Multiple
D006063:Chorionic Gonadotropin; D006062:Gonadotropins